Abstract Search

ea0034p229 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2014

The effects of treatment with Liraglutide on atherothrombotic risk in obese young women with polycystic ovary syndrome and controls

Kahal Hassan , Aburima Ahmed , Ungvari Tamas , Rigby Alan , Coady Anne-Marie , Vince Rebecca , Ajjan Ramzi , Kilpatrick Eric , Naseem Khalid , Atkin Stephen

Introduction: Polycystic ovary syndrome (PCOS) is associated with obesity and increased cardiovascular (CV) risk markers.Objective: To assess the effects of 6 months treatment with liraglutide 1.8 mg od on obesity, and CV risk markers, particularly platelet function, in young obese women with PCOS compared to matched controls.Design: Interventional casecontrol study. Carotid intima-media wall thickness (cIMT) was measured by ...

0 shares

ea0031p207 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2013

Polycystic ovary syndrome has no independent effect on vascular, inflammatory or thrombotic markers when matched for obesity

Kahal Hassan , Aburima Ahmed , Ungvari Tamas , Rigby Alan , Dawson Alison , Coady Anne-Marie , Vince Rebecca , Ajjan Ramzi , Kilpatrick Eric , Naseem Khalid , Atkin Stephen

Introduction: Previous studies investigating cardiovascular (CV) risk in obese women with polycystic ovary syndrome (PCOS) have been potentially confounded by not adequately accounting for body weight.Objective: To assess if PCOS increases CV risk independently in young obese women by examining carotid intima-media wall thickness (cIMT) and platelet function.Design: A cross-sectional study comparing women with PCOS (n=21) ...

0 shares

Endocrine Abstracts

The effects of treatment with Liraglutide on atherothrombotic risk in obese young women with polycystic ovary syndrome and controls

Polycystic ovary syndrome has no independent effect on vascular, inflammatory or thrombotic markers when matched for obesity

BiosciAbstracts